| Financier | Commitments |
|---|---|
| International Bank for Reconstruction and Development | 420.00 |
Strengthening Universal Health Insurance in Costa Rica
Abstract*
The development objectives of the Program-for-Results (PforR) : Strengthening Universal Health Insurance in Costa Rica Project for Costa Rica are to contribute to: (i) improving the timeliness and quality of health services; and (ii) enhancing the institutional efficiency of the Costa Rican social security administration (CCSS). The program will support all critical areas of strategic agenda for strengthening the health insurance (SASHI). It will... Show More
Development Objective
The objectives of the Program are to contribute to: (i) improving the timeliness and quality of health services; and (ii) enhancing the institutional efficiency of the CCSS.
Key Details
Project Details
P148435
Closed
Laura Di Giorgio
Republic of Costa Rica
Costa Rica
January 7, 2016
(as of board presentation)
March 15, 2016
November 17, 2016
US$ 420.00 million
Caja Costarricense del Seguro Social
2016
US$ 420.00 million
N/A
N/A
January 31, 2024
TBD
BANK APPROVED
May 9, 2024
Finances
Financing Plan (US$ Millions)
Total Project Financing (US$ Millions)
| Product Line | IBRD/IDA |
|---|---|
| IBRD Commitment | 420.00 |
| IDA Commitment | N/A |
| IBRD + IDA Commitment | 420.00 |
| Lending Instrument | |
|---|---|
| Grant Amount | N/A |
| Total Project Cost** | 420.00 |
Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025
No data available.
| Period | Financier | Transaction Type | Amount (US$) |
|---|---|---|---|
| Aug 15, 2019 | IBRD-85930 | Int Charges | 35,733.43 |
| Aug 15, 2019 | IBRD-85930 | Int Charges | 567,466.56 |
| Aug 15, 2019 | IBRD-85930 | Int Charges | 235,582.19 |
| Aug 15, 2019 | IBRD-85930 | Int Charges | 4,966,187.50 |
| Feb 15, 2020 | IBRD-85930 | Int Charges | 170,023.31 |
| Feb 15, 2024 | IBRD-85930 | Loan Repay | 7,665,000.00 |
| Aug 15, 2023 | IBRD-85930 | Int Charges | 13,868,321.00 |
| Aug 15, 2023 | IBRD-85930 | Loan Repay | 7,665,000.00 |
| Aug 15, 2024 | IBRD-85930 | Int Charges | 73,169.45 |
| Aug 15, 2024 | IBRD-85930 | Loan Repay | 7,665,000.00 |
| Aug 15, 2024 | IBRD-85930 | Int Charges | 14,668,835.00 |
| Feb 15, 2020 | IBRD-85930 | Int Charges | 6,164.38 |
| Feb 15, 2020 | IBRD-85930 | Int Charges | 103,585.62 |
| May 11, 2020 | IBRD-85930 | Loan Disb | 20,000,000.00 |
| May 12, 2020 | IBRD-85930 | Loan Disb | 30,000,000.00 |
| Jun 16, 2020 | IBRD-85930 | Loan Disb | 55,000,000.00 |
| Aug 15, 2020 | IBRD-85930 | Int Charges | 112,704.92 |
| Aug 15, 2020 | IBRD-85930 | Int Charges | 5,286,400.00 |
| Feb 15, 2021 | IBRD-85930 | Int Charges | 22,540.99 |
| Feb 15, 2021 | IBRD-85930 | Int Charges | 285,459.00 |
| Feb 15, 2021 | IBRD-85930 | Int Charges | 37,730.18 |
| Feb 15, 2021 | IBRD-85930 | Int Charges | 3,966,733.20 |
| Aug 15, 2021 | IBRD-85930 | Int Charges | 37,191.76 |
| Aug 15, 2021 | IBRD-85930 | Int Charges | 3,647,150.00 |
| Feb 15, 2022 | IBRD-85930 | Int Charges | 37,808.20 |
| Feb 15, 2022 | IBRD-85930 | Int Charges | 3,607,933.20 |
| Aug 15, 2022 | IBRD-85930 | Int Charges | 37,191.76 |
| Aug 15, 2022 | IBRD-85930 | Int Charges | 4,882,475.00 |
| Aug 15, 2022 | IBRD-85930 | Loan Repay | 7,098,000.00 |
| Nov 22, 2016 | IBRD-85930 | Fee Charges | 1,050,000.00 |
| Dec 22, 2016 | IBRD-85930 | Loan Disb | 105,000,000.00 |
| Feb 15, 2017 | IBRD-85930 | Int Charges | 649,343.10 |
| Aug 15, 2017 | IBRD-85930 | Int Charges | 417,652.38 |
| Aug 15, 2017 | IBRD-85930 | Int Charges | 390,513.70 |
| Aug 15, 2017 | IBRD-85930 | Int Charges | 1,578,470.90 |
| Aug 15, 2017 | IBRD-85930 | Int Charges | 39,535.14 |
| Feb 15, 2018 | IBRD-85930 | Int Charges | 396,986.30 |
| Feb 15, 2018 | IBRD-85930 | Int Charges | 1,669,033.40 |
| Aug 15, 2018 | IBRD-85930 | Int Charges | 390,513.70 |
| Aug 15, 2018 | IBRD-85930 | Int Charges | 1,958,570.90 |
| Nov 26, 2018 | IBRD-85930 | Loan Disb | 30,000,000.00 |
| Feb 15, 2019 | IBRD-85930 | Int Charges | 344,589.03 |
| Feb 15, 2019 | IBRD-85930 | Int Charges | 2,513,333.20 |
| Dec 19, 2018 | IBRD-85930 | Loan Disb | 90,000,000.00 |
| Jul 31, 2019 | IBRD-85930 | Loan Disb | 60,000,000.00 |
| Feb 15, 2024 | IBRD-85930 | Int Charges | 15,121,728.00 |
| Feb 15, 2020 | IBRD-85930 | Int Charges | 5,360,533.50 |
| Mar 15, 2016 | IBRD-85930 | Loan Commitment | 420,000,000.00 |
| Feb 16, 2023 | IBRD-85930 | Loan Disb | 30,000,000.00 |
| Feb 15, 2023 | IBRD-85930 | Int Charges | 37,808.20 |
| Feb 15, 2023 | IBRD-85930 | Int Charges | 10,059,261.00 |
| Feb 15, 2023 | IBRD-85930 | Loan Repay | 7,098,000.00 |
| Aug 15, 2023 | IBRD-85930 | Int Charges | 205.48 |
Ratings
IMPLEMENTATION RATINGS
| Name | Review | Date |
|---|---|---|
| Progress towards achievement of PDO | Satisfactory | 2023-12-21 |
| Monitoring and Evaluation | Satisfactory | 2023-12-21 |
| Overall Implementation Progress (IP) | Satisfactory | 2023-12-21 |
COMPLETION RATINGS
No data available.
INDEPENDENT EVALUATION RATINGS
| INDICATOR | ICR REVIEW: 03-12-2025 | PROJECT PERFORMANCE ASSESSMENT REPORT: |
|---|---|---|
| Outcome Rating | Highly Satisfactory | N/a |
| Risk To Development Outcome | N/a | |
| Bank Performance | Highly Satisfactory | N/a |
| Borrower Performance | N/a | |
| Government Performance | N/a | |
| Implementing Agency | N/a | |
| Icr Quality | High | N/a |
| M&e Quality | Substantial | N/a |
Results Framework
PROJECT DEVELOPMENT OBJECTIVE INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Percentage of major surgeries from priority list conducted in outpatient settings according to CCSS institutional guidelines Value 18.00 40.00 46.00 Date February 29, 2016 March 16, 2021 August 2, 2018 Comment Percentage of total number of primary health care units (Areas de Salud) with the Unique Digital Health Record e-health package (EDUS) Value 50.00 90.10 0.00 Date February 29, 2016 December 31, 2021 Comment Cumulative percentage of target population personally invited to undergo colon cancer screening in five priority counties. Value 0.00 40.10 0.00 Date February 29, 2016 July 21, 2022 Comment Development and execution of a comprehensive medium-and long-term plan to ensure the financial sustainability of the CCSS Value Budget does not use prospective tools. Target achieved in January 2024. Annual budget execution using prospective tools Date February 29, 2016 January 31, 2024 January 31, 2024 Comment
INTERMEDIATE RESULTS INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Cumulative percentage reduction in average waiting days for selected procedures (tracers): hip and knee replacement. Value 1032 days 671 (35% lower) Date February 29, 2016 March 16, 2022 Comment Percentage of households covered by the Family Socio-Economic & Health Risks Information File. Value 70.00 100.00 0.00 Date February 29, 2016 March 16, 2022 Comment Financial statements produced using new international public accounting standards, streamlined and digital automated processes. Value - In progress Annual Financial Statement using outputs from new Date February 29, 2016 November 18, 2022 January 31, 2024 Comment Percentage of individuals diagnosed with hypertension that are under optimal clinical control. Value 62.00 65.70 0.00 Date December 31, 2013 June 15, 2020 Comment Percentage of households with Family Socio-Economic & Health Risks Information File digital geo-referencing data available online. Value 0.00 66.90 0.00 Date February 29, 2016 April 17, 2023 Comment Shadow budget constructed based on gender and age risk adjusted capitations. Value - Achieved Date February 29, 2016 December 8, 2023 Comment Use of institutional strategic intelligence system data to publish and disseminate two annual reports measuring progress of SASHI Value - System designed, approved by Board of Directors an Two annual reports published and disseminated Date February 29, 2016 December 19, 2023 January 31, 2024 Comment Institutional Review of core institutional management functions, and operational plan for progressive implementation of streamlining central level management. Value - Approved by the Board of Directors Date February 29, 2016 December 31, 2021 Comment